Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISTAS: Volixibat in Primary Sclerosing Cholangitis
NCT04663308Phase 2Active, not recruiting
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- Dec 2020
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of volixibat in Primary Sclerosing Cholangitis (PSC), sponsored by Mirum Pharmaceuticals, Inc.. Started Dec 2020; status: active, not recruiting.
02
Drugs
volixibat
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT04663308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04663308.